Modeling and prediction of subject accrual and event times in clinical trials: A systematic review

Clinical Trials

Volumn 9, Issue 6, 2012, Pages 681-688

  Zhang, Xiaoxi ^a   Long, Qi ^b  

^a PFIZER INC   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; FOLLOW UP; HUMAN; MODEL; POISSON DISTRIBUTION; PREDICTION; PRIORITY JOURNAL; STOCHASTIC MODEL; SYSTEMATIC REVIEW;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; LOST TO FOLLOW-UP; MODELS, STATISTICAL; MULTICENTER STUDIES AS TOPIC; PATIENT SELECTION; POISSON DISTRIBUTION; STATISTICS, NONPARAMETRIC; STOCHASTIC PROCESSES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84871827839     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774512447996     Document Type: Conference Paper

References (24)

1. Van Cutsem E, Labianca R, Bodoky G, et al. Randomized phase III trial comparing biweekly infusional 5-fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J Clin Oncol. 2009 ; 27: 2117-25
2. BarnesK. Pharma giants risk reputation through clinical trial cost-cutting, Available at: http://www.outsourcing-pharma.com/Clinical- Development/Pharma-giants-risk-reputation-through-clinical-trial-cost-cutting (accessed 25 December 2010).
3. YingGS. Prediction of event times in randomized clinical trials. Dissertations, ProQuest, Paper AAI3125925, 2004. Available at: http://repository.upenn.edu/dissertations/AAI3125925
4. Ross SM Stochastic Processes. 2 nd edn). Wiley, New York, 1995. New York: Wiley ; 1995:
5. Lai D, Moye LA, Davis BR, Brown LE, Sacks FM. Brownian motion and long-term clinical trial recruitment. J Stat Plan Infer. 2001 ; 93: 239-46 (Pubitemid 33626383)
6. Zhang Q, Lai D. Fractional Brownian motion and long term clinical trial recruitment. J Stat Plan Infer. 2010 ; 141: 1783-88
7. Beran J Statistics for Long-Memory Processes. Chapman & Hall/CRC ; 1994:
8. Gajewski BJ, Simon SD, Carlson SE. Predicting accrual in clinical trials with Bayesian posterior predictive distributions. Stat Med. 2008 ; 27: 2328-40 (Pubitemid 351802897)
9. Anisimov VV, Fedorov VV. Modelling, prediction and adaptive adjustment of recruitment in multicentre trials. Stat Med. 2007 ; 26: 4958-75 (Pubitemid 350064916)
10. Cox DR. Some statistical methods connected with series of events. J Roy Stat Soc B. 1955 ; 17: 129-64
11. Zhang X, Long Q. Stochastic modeling and prediction for accrual in clinical trials. Stat Med. 2010 ; 29 (6). 649-58
12. Zhang X, Long Q Bayesian modeling and prediction of patient accrual in multi-regional clinical trials. Department of Biostatistics and Bioinformatics, Emory University ;
13. Bagiella E, Heitjan DF. Predicting analysis times in randomized clinical trials. Stat Med. 2001 ; 20: 2055-63 (Pubitemid 32684628)
14. Ying GS, Heitjan DF. Weibull prediction of event times in clinical trials. Pharm Stat. 2008 ; 7: 107-20 (Pubitemid 351943639)
15. Balasooriya U, Abeysinghe T. Selecting between gamma and Weibull distribution-an approach based on predictions of order statistics. J Appl Stat. 1994 ; 21: 17-27
16. Carroll KJ. On the use and utility of the Weibull model in analysis of survival data. Control Clin Trials. 2003 ; 24: 682-701 (Pubitemid 37518386)
17. Ying GS, Heitjan DF, Chen TT. Nonparametric prediction of event times in randomized clinical trials. Clin Trials. 2004 ; 1: 352-61
18. Rubin DB. The Bayesian bootstrap. Annals Stat. 1981 ; 9: 130-34
19. Donovan JM, Elliott MR, Heitjan DF. Predicting event times in clinical trials when treatment arm is masked. J Biopharm Stat. 2006 ; 16: 343-56
20. Zhang X, Long Q. Joint monitoring and prediction of accrual and event times in clinical trials. Biometrical Journal. 2012 ;:
21. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991 ; 324: 509-16
22. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med. 2000 ; 343: 905-14
23. Beyersmann J, Latouche A, Buchholz A, Schumacher M. Simulating competing risks data in survival analysis. Stat Med. 2009 ; 28: 956-71
24. Allignol A, Schumacher M, Wanner C, Drechsler C, Beyersmann J. Understanding competing risks: a simulation point of view. BMC Med Res Methodol. 2011 ; 11: 86